glp-1 pharmacology Receptor Agonist Services for Type 2 Diabetes and Obesity Drug Development Mechanisms of Action and Therapeutic

Description

Now it has been shown that limited experimental data can be used to train sophisticated machine learning models to accurately predict the activity of previously uncharacterized peptide ligand variants.

A study of nearly 1.1 million people found that semaglutide (the drug in Ozempic and Wegovy) was associated with a 40-70% lower risk of developing Alzheimer's compared to other diabetes medications

#Endocrinology #Diabetes #ObesityMedicine #GLP1RA #ThyroidHealth #EvidenceBasedMedicine #ClinicalPractice

GLP-1 RAs are used for managing blood glucose levels in people with type 2 diabetes mellitus and have also been licensed for use in weight loss treatment

Many endocrinologists are now recommending GLP-1 drugs as first line injectables therapy over the insulin for many Type II diabetes as GLP-1 benefits outweighs Insulin